Inicio › Cáncer de pulmón de células no pequeñas › Minnesota › Saint Paul
Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Saint Paul, MN
19 estudios para Cáncer de pulmón de células no pequeñas buscan participantes en centros de Saint Paul y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
ReclutandoFase 3
- United Hospital, Saint Paul
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- Regions Hospital, Saint Paul
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 2
- Health Partners Cancer Center at Regions Hospital, Saint Paul
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ReclutandoFase 3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
ReclutandoFase 3
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Minnesota Oncology Hematology, P.A., Maplewood · A 5 mi de distancia
- Minnesota Oncology Hematology, PA, Woodbury · A 7 mi de distancia
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ReclutandoFase 3
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Minnesota Oncology Hematology, P.A., Maplewood · A 5 mi de distancia
- Minnesota Oncology Hematology, P.A., Woodbury · A 7 mi de distancia
- y 1 más
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
ReclutandoFase 3
- Regions Hospital, Saint Paul
- M Health Fairview St. John's Hospital, Maplewood · A 5 mi de distancia
- Minnesota Oncology Hematology PA, Maplewood · A 5 mi de distancia
- y 1 más
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
ReclutandoFase 2
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · A 5 mi de distancia
- y 3 más
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
ReclutandoFase 3
- Clinical Study Site, Saint Paul
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- HealthPartners Cancer Research Center, Saint Paul
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
ReclutandoFase 3
- Research Site, Saint Paul
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ReclutandoFase 1/2
- USOR Minnesota Oncology Hematology, Maplewood · A 5 mi de distancia
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
ReclutandoFase 1/2
- Health Partners Cancer Center at Regions Hospital, Saint Paul
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
ReclutandoFase 1/2
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ReclutandoFase 1
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Allina Health Cancer Institute, Saint Paul
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Woodbury, Woodbury · A 7 mi de distancia
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · A 5 mi de distancia
- y 3 más
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
ReclutandoFase 1/2
- Research Site 121, Saint Paul
Ensayos de Cáncer de pulmón de células no pequeñas en otras ciudades
- Houston, TX145 estudios
- New York City, NY121 estudios
- Arlington, VA104 estudios
- Nashville, TN97 estudios
- Boston, MA90 estudios
- Los Angeles, CA87 estudios
- St. Louis, MO73 estudios
- Chicago, IL61 estudios
- Baltimore, MD60 estudios
- San Antonio, TX59 estudios
- Columbus, OH57 estudios
- Washington, DC55 estudios
Otros estudios en Saint Paul
- Cáncer de próstata13 estudios
- Cáncer de pulmón13 estudios
- Cáncer de seno12 estudios
- Cáncer del colon y del recto9 estudios
- Cáncer de ovario8 estudios
- Cáncer metastásico7 estudios
- Cáncer de riñón (carcinoma de células renales)7 estudios
- Cáncer de endometrio6 estudios
- Cáncer de vejiga6 estudios
- Melanoma6 estudios
- Carcinoma de células escamosas de cabeza y cuello6 estudios
- Leucemia mielógena aguda6 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.